ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (599 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.pep.2008.09.009    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2008 Elsevier Inc. All rights reserved.

Periplasmic cold expression and one-step purification of human dihydrolipoamide dehydrogenase

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Attila AmbrusCorresponding Author Contact Information, a, E-mail The Corresponding Author, Beata Torocsika and Vera Adam-Vizia

aNeurobiochemistry Research Group, Department of Medical Biochemistry, Semmelweis University, Hungarian Academy of Sciences, Szentagothai Janos Knowledge Center, 9 Puskin Street, H-1088 Budapest, Hungary


Received 25 June 2008; 
revised 10 September 2008. 
Available online 23 September 2008.

Abstract

Dihydrolipoamide dehydrogenase (LADH) is a FAD-linked subunit of α-ketoglutarate, pyruvate and branched-chain amino acid dehydrogenases and the glycine cleavage system. As an oxidoreductase it transfers electrons from the dihydrolipoic acid prosthetic group to the NAD+ cofactor via its FAD center. Besides its physiological function it is capable of generating harmful reactive oxygen species (ROS) in pathological settings therefore it is implicated in neurodegeneration, ischemia-reperfusion, cancer and several other disorders. Pathological mutants of the enzyme cause severe, sometimes lethal syndromes like hypotonia, metabolic acidosis or inefficiency in development. Recently it has been revealed that LADH is a moonlighting protease when specific mutations in the dimerization surface destabilize the functional homodimer and expose a serine-protease-like catalytic dyad. As the basis of versatile functions of LADH is far from elucidation, there is a constant need for a pure and functional enzyme product for investigations. Several studies used recombinant human LADH before, however, it was generated by more complicated and/or physiologically less compatible protocols than reported here; most papers on functional and structural studies do not even report detailed protocols and characteristics (most importantly the purity) of their protein products. Here we describe the details of an optimized, easy-to-use periplasmic expression and one-step purification protocol for obtaining a highly pure, active and authentic (tag-cleaved) enzyme with the characterization of the protein product. The purified LADH can be used in biophysical and structural studies while the published protocol is easily convertible to a protein labeling procedure.

Keywords: α-Ketoglutarate dehydrogenase; Dihydrolipoamide dehydrogenase; LADH; Escherichia coli; Strep-tag; Periplasmic expression

Article Outline

Materials and methods
Materials
Plasmid construction and DNA manipulations
Protein expression and purification
Factor Xa cleavage
Activity assay
SDS–PAGE and immunoblotting
Mass spectrometry
Circular dichroism (CD) measurements
Results and discussion
Acknowledgements
Appendix A. Supplementary data
References








Corresponding Author Contact InformationCorresponding author. Fax: +36 1 267 0031.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.